Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-067682
Filing Date
2025-07-14
Accepted
2025-07-14 12:54:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2520238d2_defa14a.htm DEFA14A 56234
  Complete submission text file 0001104659-25-067682.txt   57261
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-37410 | Film No.: 251120896
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)